Cargando…
Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558052/ https://www.ncbi.nlm.nih.gov/pubmed/37809340 http://dx.doi.org/10.3389/fmed.2023.1289307 |
| _version_ | 1785117202492424192 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10558052 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105580522023-10-07 Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial Front Med (Lausanne) Medicine Frontiers Media S.A. 2023-09-19 /pmc/articles/PMC10558052/ /pubmed/37809340 http://dx.doi.org/10.3389/fmed.2023.1289307 Text en Copyright © 2023 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial |
| title | Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial |
| title_full | Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial |
| title_fullStr | Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial |
| title_full_unstemmed | Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial |
| title_short | Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial |
| title_sort | erratum: efficacy and safety of single-dose ivermectin in mild-to-moderate covid-19: the double-blind, randomized, placebo-controlled corvette-01 trial |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558052/ https://www.ncbi.nlm.nih.gov/pubmed/37809340 http://dx.doi.org/10.3389/fmed.2023.1289307 |
| work_keys_str_mv | AT erratumefficacyandsafetyofsingledoseivermectininmildtomoderatecovid19thedoubleblindrandomizedplacebocontrolledcorvette01trial |